# Recommended Dose Estimation of BP-C2

> **NCT04186585** · PHASE1 · RECRUITING · sponsor: **Meddoc** · enrollment: 8 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** BP-C2

## Key facts

- **NCT ID:** NCT04186585
- **Lead sponsor:** Meddoc
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2025-09-30
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2025-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04186585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04186585, "Recommended Dose Estimation of BP-C2". Retrieved via AI Analytics 2026-09-13 from https://api.ai-analytics.org/clinical/NCT04186585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*